Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
BlackRock LifePath Index's forward-thinking management team, research-intensive process, extremely low costs, and high-quality building blocks place this series among the industry's very best options. It continues to earn a Morningstar Analyst Rating of Gold.
